ADSS: A Composite Score to Detect Disease Progression in Alzheimer's Disease.
J Alzheimers Dis Rep
; 8(1): 307-316, 2024.
Article
in En
| MEDLINE
| ID: mdl-38405343
ABSTRACT
Background:
Composite scores have been increasingly used in trials for Alzheimer's disease (AD) to detect disease progression, such as the AD Composite Score (ADCOMS) in the lecanemab trial.Objective:
To develop a new composite score to improve the prediction of outcome change.Methods:
We proposed to develop a new composite score based on the statistical model in the ADCOMS, by removing duplicated sub-scales and adding the model selection in the partial least squares (PLS) regression.Results:
The new AD composite Score with variable Selection (ADSS) includes 7 cognitive sub-scales. ADSS can increase the sensitivity to detect disease progression as compared to the existing total scores, which leads to smaller sample sizes using the ADSS in trial designs.Conclusions:
ADSS can be utilized in AD trials to improve the success rate of drug development with a high sensitivity to detect disease progression in early stages.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Alzheimers Dis Rep
Year:
2024
Type:
Article
Affiliation country:
United States